AstraZeneca PLC — Investor Relations & Filings
AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Tezspire Recommended for Approval in EU for CRSwNP | 2025-09-22 | English | |
| SAPHNELO MET PRIMARY ENDPOINT IN TULIP-SC | 2025-09-17 | English | |
| UPDATE ON RESOLUTE PHASE III TRIAL | 2025-09-17 | English | |
| Saphnelo met primary endpoint in TULIP-SC | 2025-09-17 | English | |
| Update on RESOLUTE Phase III trial | 2025-09-17 | English | |
| TOTAL VOTING RIGHTS | 2025-09-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 7877828 | Tezspire Recommended for Approval in EU for CRSwNP | 2025-09-22 | English | ||
| 10017325 | SAPHNELO MET PRIMARY ENDPOINT IN TULIP-SC | 2025-09-17 | English | ||
| 10017327 | UPDATE ON RESOLUTE PHASE III TRIAL | 2025-09-17 | English | ||
| 7833772 | Saphnelo met primary endpoint in TULIP-SC | 2025-09-17 | English | ||
| 7833725 | Update on RESOLUTE Phase III trial | 2025-09-17 | English | ||
| 10017328 | TOTAL VOTING RIGHTS | 2025-09-02 | English | ||
| 11382012 | Total Voting Rights | 2025-09-01 | English | ||
| 10017333 | HOLDING(S) IN COMPANY | 2025-08-28 | English | ||
| 7772647 | Holding(s) in Company | 2025-08-28 | English | ||
| 10017331 | HOLDING(S) IN COMPANY | 2025-08-26 | English | ||
| 7768729 | Holding(s) in Company | 2025-08-26 | English | ||
| 7768117 | Major Shareholding Notification 2025 | 2025-08-26 | Swedish | ||
| 10017329 | HOLDING(S) IN COMPANY | 2025-08-21 | English | ||
| 7757761 | Holding(s) in Company | 2025-08-21 | English | ||
| 7757197 | Major Shareholding Notification 2025 | 2025-08-21 | Swedish | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for AstraZeneca PLC, but not for this combination of statement and period. Try a different combination.
| Line item | ! |
|---|---|
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AstraZeneca PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5229/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5229 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5229 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5229 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5229}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AstraZeneca PLC (id: 5229)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.